Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryReal-world data and analytics platform that supports clinical trial design, feasibility, site identification, recruitment planning, and evidence generation.
Research organizations that need cohort feasibility, site intelligence, and real-world data analytics before launching or adapting clinical trials.
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating TriNetX as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as clinical research, feasibility, and real-world evidence infrastructure unless a deployment directly affects patient care; align use with protocol, IRB, sponsor, and regional research rules. |
|---|---|
| Privacy | Review federation model, data rights, de-identification or pseudonymization, site-level patient re-identification workflow, audit logs, retention, and cross-border data controls. |
| Evidence | Validate cohort counts, criteria logic, ontology mappings, missing-data assumptions, site performance signals, and diversity metrics against known local or sponsor trial data. |
| Workflow | Best used as decision support for study teams, with documented human confirmation before protocol amendments, site selection, patient outreach, or RWE conclusions. |
TriNetX describes a global real-world data network for trial feasibility, protocol optimization, patient-population matching, site intelligence, and AI-supported clinical research analytics.
Not for: Direct treatment selection, automated patient outreach, or protocol decisions without investigator, privacy, IRB, sponsor, and site governance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.